Skip to main content
. 1996 Nov 26;93(24):13967–13972. doi: 10.1073/pnas.93.24.13967

Figure 1.

Figure 1

Effect of anti-CD40L mAb on cardiac allograft survival. BALB/c hearts were transplanted into C57BL/6 recipients. Allograft recipients were treated with either a control Ig or anti-CD40L mAb (200 μg by intravenous injection) at the time of transplantation. Selected recipients also received a transfusion of 5 × 106 donor lymphocytes (DST) at the time of transplantation.